Clinical Significance: Midazolam is a benzodiazepine used to treat insomnia and seizures.
Tested in urine only
Drug Class
Benzodiazepines
Metabolite(s)
None
Aliases
Dormonid
Methodology
Enzyme Immunoassay/Liquid Chromatography Mass Spectrometry
Urine Recommended Volume
30mL
Oral Fluid Minimum Volume
N/A
Specimen Stability
15 days
Urine Reportable Range
20-400
Oral Fluid Reportable Range
N/A
Urine Immunoassay Cutoff (ng/mL)
200
Urine Window of Detection
2-3 days
Oral Fluid Window of Detection
N/A
Rejection Criteria
Quantity Not Sufficient
Urine Transient Contanier
Urine Clinical Drug Test Transport Cup
Oral Fluid Transient Contanier
N/A